Fertility Testing Is Big Business—But Is It Really Helping You Get Pregnant?
By Elissa Strauss,
Glamour Magazine [cites CGS' Fellow Gina Maranto]
| 12. 28. 2017
New evidence shows that the tests many companies use to determine a woman's chances of having a baby are based on bogus science.
"Learn how many high quality eggs you have remaining and your chances of getting pregnant now and in the future,” beckons Egg-Q, one of the handful of new startups offering fertility testing to women concerned about their reproductive potential. The desire to know “how long you have left to conceive,” as offered by LetsGetChecked, or, more simply, “powerful information about your fertility,” courtesy of Modern Fertility, is understandable. Women are having children later than ever, a shift that has proved professionally and personally beneficial, but reproductively challenging. When offered a fertility magic eight ball, many can’t help but take a peek, hoping to discover something, anything, about their baby-making future.
If only that was possible.
These fertility blood tests provide women with an assortment of figures and graphs charting their ovarian reserve, along with a few other measures that will present themselves as authoritative, fate-determining even. But in reality, they offer little more than...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...